Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 17/20 | 0.50 |
| ▸ | EGLN3 | Q9H6Z9 | 3/20 | 0.49 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | VEGFA | P15692 | 2/20 | 0.46 |
| ▸ | FLT1 | P17948 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL964980 | 0.91 | EGLN1 (0.50) | EGLN1EGLN3FTOALDH1A1LMNA | |
| SCHEMBL6565270 | 0.88 | EGLN1 (0.47) | EGLN1EGLN3FTOALDH1A1LMNA | |
| SCHEMBL6567272 | 0.88 | EGLN1 (0.47) | EGLN1EGLN3FTOALDH1A1LMNA | |
| SCHEMBL6566238 | 0.88 | EGLN1 (0.47) | EGLN1EGLN3FTOALDH1A1LMNA | |
| SCHEMBL1509148 | 0.86 | EGLN1 (0.50) | EGLN1EGLN3FTOVEGFAFLT1 | |
| SCHEMBL6564152 | 0.83 | EGLN1 (0.57) | EGLN1EGLN3FTO | |
| SCHEMBL6565277 | 0.83 | EGLN1 (0.47) | EGLN1EGLN3FTOVEGFAFLT1 | |
| SCHEMBL8625366 | 0.81 | EGLN1 (0.44) | EGLN1EGLN3ALDH1A1LMNA | |
| SCHEMBL6566125 | 0.81 | EGLN1 (0.52) | EGLN1EGLN3FTOVEGFAFLT1 | |
| SCHEMBL8633329 | 0.80 | EGLN1 (0.54) | EGLN1FTO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0765871-B1 | Substituted Quinoline-2-carboxamides, their preparation and their use as prolyle-4-hydroxylase Inhibitors | FIBROGEN INC (US) | 2004-03-31 | — | — | EP | disclosed |
| US-5726305-A | Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-03-10 | — | — | US | disclosed |
| US-5719164-A | Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-02-17 | — | — | US | disclosed |
| US-5620995-A | Substituted heterocyclic carboxyamides, their preparation and their use as pharmaceuticals | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-04-15 | — | — | US | disclosed |
| EP-0765871-A1 | Substituted Quinoline-2-carboxamides, their preparation and their use as prolyle-4-hydroxylase Inhibitors | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-04-02 | — | — | EP | disclosed |
| EP-0661269-B1 | Substituted heterocyclic carboxylic acid amides, their preparation and their use as medicaments | HOECHST AG (DE) | 1997-03-26 | — | — | EP | disclosed |
| CN-1126203-A | Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals | HOECHST AG (DE) | 1996-07-10 | — | — | CN | disclosed |
| EP-0661269-A1 | Substituted heterocyclic carboxylic acid amides, their preparation and their use as medicaments | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-07-05 | — | — | EP | disclosed |